4
Changes in Ownership
Denali Therapeutics Inc. Filed Acc 0001209191-21-021122
CFO and Treasurer sold 50,000 shares at an average $61.89 ($3,094,563)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Krognes Steve E. CFO and Treasurer | 2021-03-15 | Sale | −13,258 | $61.16 | $810,912 | 886,742 | I |
| Krognes Steve E. CFO and Treasurer | 2021-03-15 | Sale | −32,326 | $62.04 | $2,005,602 | 854,416 | I |
| Krognes Steve E. CFO and Treasurer | 2021-03-15 | Sale | −3,258 | $62.71 | $204,319 | 851,158 | I |
| Krognes Steve E. CFO and Treasurer | 2021-03-15 | Sale | −1,158 | $63.67 | $73,730 | 850,000 | I |
| Open-market sales · 50,000 sh · avg $61.89 · $3,094,563 | |||||||
Loading xslF345X03/doc4.xml…